Afficher la fiche abrégée

dc.contributor.authorExecutive Board, 34
dc.coverage.spatialGenevaEN
dc.date.accessioned2014-10-25T12:56:33Z
dc.date.available2014-10-25T12:56:33Z
dc.date.issued1964
dc.identifier.govdocEB34/13
dc.identifier.govdocEB34/13 Corr.1
dc.identifier.urihttps://iris.who.int/handle/10665/137188
dc.description(‎Agenda item 3.3)‎EN
dc.language.isoenEN
dc.publisherWorld Health OrganizationEN
dc.subject.meshHelminthiasisEN
dc.subject.meshPharmaceutical PreparationsEN
dc.subject.meshReference StandardsEN
dc.subject.meshMental HealthEN
dc.subject.meshPsychosomatic MedicineEN
dc.subject.meshAir PollutionEN
dc.subject.meshSubstance-Related DisordersEN
dc.subject.meshNeoplasmsEN
dc.subject.meshGeneticsEN
dc.subject.meshPublic HealthEN
dc.subject.meshSmallpoxEN
dc.subject.meshInsecticidesEN
dc.subject.meshDrugs, GenericEN
dc.subject.meshPesticide ResiduesEN
dc.subject.meshBrucellosisEN
dc.titleReport of expert committee meetings: report by the Director-GeneralEN
dc.typeGoverning body documentsEN
dc.subject.meshqualifierprevention and controlEN


Fichier(‎s)‎ constituant ce document

Thumbnail

Ce document figure dans la(‎les)‎ collection(‎s)‎ suivante(‎s)‎

Afficher la fiche abrégée